SCHEMBL20152298

SCHEMBL20152298

Cc1c2c3ccccc3n(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c2c(C)c2c3ccccc3n(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c12

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
ATM Q13315 1/20 0.39
MAPT P10636 2/20 0.36
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 1/20 0.35
TSHR P16473 1/20 0.35
BRCA1 P38398 1/20 0.35
IL1R1 P14778 1/20 0.34
HTT P42858 1/20 0.33
HPGD P15428 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
TOP2A P11388 1/20 0.32
AVPR1A P37288 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152293 0.96 L3MBTL1 (0.40) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL20152294 0.88 ATM (0.41) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL20152289 0.87 L3MBTL1 (0.46) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL20152297 0.87 L3MBTL1 (0.46) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL20152292 0.87 L3MBTL1 (0.46) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL20152296 0.85 L3MBTL1 (0.42) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL21108862 0.84 L3MBTL1 (0.50) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL15128415 0.83 L3MBTL1 (0.47) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL21109238 0.83 L3MBTL1 (0.48) KDM4EL3MBTL1ATMMAPTKMT2A
SCHEMBL17123102 0.83 L3MBTL1 (0.48) KDM4EL3MBTL1ATMMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180138425-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180138425-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES DDT, OCIAD1, OCIAD2 KDM4E 1178/4885L3MBTL1 430/4885ATM 4294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.